AERIUS 5 MG — DIN 02243919
DESLORATADINE : 5 MG · BAYER INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is AERIUS?
AERIUS 5 MG contains DESLORATADINE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02243919, held by BAYER INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 03-Feb-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AERIUS used for?
AERIUS® (desloratadine) tablets and AERIUS KIDS® (desloratadine) syrup are indicated for fast 24-hour and effective relief of multi nasal and non-nasal symptoms associated with allergic rhinitis, including sneezing, nasal discharge/rhinorrhea and itching, nasal congestion/stuffiness, itching of the palate and/or ears and/or throat and/or eyes and allergic cough, as well as burning, swollen, tearing and redness of the eyes. They are also indicated for rapid and effective relief of symptoms associated with chronic idiopathic urticaria, such as pruritus and hives.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Desloratadine cost around the world?
Desloratadine is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 24 | 52 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 13 | 42 | CZK███.██ |
| Saudi Arabia | public | 28 | 32 | SAR███.██ |
| Bahrain | retail (max) | 16 | 29 | BHD███.██ |
| United Arab Emirates | public | 16 | 21 | AED███.██ |
| Austria | KVP (Kassenverkaufspreis) | 7 | 14 | EUR███.██ |
| Morocco | PPV (public price) | 5 | 14 | MAD███.██ |
| Greece | producer price (ex-factory) | 8 | 8 | EUR███.██ |
| Hungary | producer price (ex-factory) | 5 | 6 | HUF███.██ |
| Luxembourg | reimbursement | 6 | 6 | EUR███.██ |
| United States | acquisition | 2 | 6 | USD███.██ |
| United Kingdom | hospital | 1 | 1 | GBP███.██ |
231 pack listings across 131 brand entries and 10 price bases, refreshed 05 Sep 2026. Ranges span every Desloratadine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Desloratadine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Desloratadine, across 9 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC | 3 | 2 | AERIUS, AERIUS KIDS | Sourceable in Canada |
| PHARMASCIENCE INC | 2 | 1 | ALLERGY CONTROL DESLORATADINE, DESLORATADINE ALLERGY CONTROL | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | DESLORATADINE | Sourceable in Canada |
| APOTEX INC | 1 | 0 | DESLORATADINE TABLETS | No marketed DIN |
| DOMINION PHARMACAL | 1 | 0 | DESLORATADINE ALLERGY CONTROL | No marketed DIN |
| TEVA CANADA LIMITED | 1 | 0 | ALLERNIX MULTI SYMPTOM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | AERIUS tablets are packaged in PVC/aluminum blisters in boxes of 10’s, 20’s, 30’s, 40’s, 50’s, 70’s and 80’s. AERIUS tablets are also available in an HDPE bottle with 24, 40ct, 70ct, 24+8ct Bonus & 40+16ct Bonus, 100, & 130 tablets. AERIUS KIDS syrup is packaged in an 100mL amber glass bottle. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Desloratadine |
|---|---|
| ATC code | R06AX27 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02243919 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243919 |
| Brand name | AERIUS |
| Generic / active ingredient | DESLORATADINE : 5 MG |
| Market authorization holder | BAYER INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AX27 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R06AX |
| Current status | MARKETED |
| Status date | 03-Feb-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 9 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AERIUS KIDS | 0.5 MG | SYRUP | BAYER INC | MARKETED | 02247193 |
| DESLORATADINE | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02546019 |
| DESLORATADINE ALLERGY CONTROL | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02298155 |
| AERIUS | 0.5 MG | SYRUP | BAYER INC | APPROVED | 02247192 |
| ALLERGY CONTROL DESLORATADINE | 5 MG | TABLET | PHARMASCIENCE INC | APPROVED | 02415771 |
| ALLERNIX MULTI SYMPTOM | 5 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02369656 |
| DESLORATADINE ALLERGY CONTROL | 5 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | 02408740 |
| DESLORATADINE TABLETS | 5 MG | TABLET | APOTEX INC | DORMANT | 02338424 |
2 · Same class — other molecules in ATC R06AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Loratadine | 24 HOUR ALLERGY REMEDY · ALLERGY REMEDY · ALLERTIN · ALLERTIN TABLETS 10MG · +13 more | 20 | 11 | Yes |
| Bilastine | AURO-BILASTINE · BLEXTEN · GLN-BILASTINE · JAMP BILASTINE · +4 more | 10 | 10 | Yes |
| Rupatadine | APO-RUPATADINE · PMS-RUPATADINE · RIVA-RUPATADINE · RUPALL | 5 | 5 | Yes |
| Desloratadine | AERIUS · AERIUS KIDS · ALLERGY CONTROL DESLORATADINE · ALLERNIX MULTI SYMPTOM · +3 more | 9 | 4 | Yes |
| Cyproheptadine | EURO-CYPROHEPTADINE 2MG/5ML · EURO-CYPROHEPTADINE 4 MG/TABLET · JAMP CYPROHEPTADINE SYRUP · JAMP-CYPROHEPTADINE · +6 more | 10 | 3 | Yes |
| Fexofenadine | ALLEGRA 12 HOUR · ALLEGRA 24 HOUR · ALLEGRA HIVES | 3 | 3 | Yes |
| Ketotifen | APO-KETOTIFEN - SYR 1MG/5ML · NOVO-KETOTIFEN - SYR 1MG/5ML · NOVO-KETOTIFEN TAB 1MG · NU-KETOTIFEN SYRUP - 1MG/5ML · +3 more | 9 | 1 | Yes |
| Other Antihistamines For Systemic Use | APO-BILASTINE ORAL SOLUTION · APO-BILASTINE ORODISPERSIBLE TABLETS · APO-BILASTINE TABLETS | 3 | 1 | Yes |
| Terfenadine | ALLERGY RELIEF · APO-TERFENADINE TAB 120MG · APO-TERFENADINE TABLETS 60MG · NOVO-TERFENADINE TAB 60MG · +7 more | 11 | 0 | Not in Canada |
| Astemizole | HISMANAL - TAB 10MG · HISMANAL SUSPENSION 2MG/ML · HISMANAL TAB 10MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R06AA | Clemastine · Dimenhydrinate · Dimenhydrinate, Combinations · Diphenhydramine · Diphenhydramine, Combinations · +3 more | 264 | 76 |
| R06AE | Cetirizine · Cyclizine · Meclozine · Meclozine, Combinations | 69 | 27 |
| R06AB | Brompheniramine · Chlorpheniramine · Dexchlorpheniramine | 17 | 1 |
| R06AD | Alimemazine · Promethazine | 17 | 1 |
| R06AC | Tripelennamine | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is AERIUS called?
The same molecule, Desloratadine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Actilor | Latin | Bahrain, United Arab Emirates |
| DESLORATADIN ZENTIVA | Latin | Czechia |
| JOVESTO | Latin | Czechia |
| Batlor | Latin | Bahrain, Saudi Arabia |
| Deselex Syrup | Latin | South Africa |
| DESLORATADIN MYLAN | Latin | Czechia |
| Aerzit Syrup | Latin | South Africa |
| DASSELTA | Latin | Czechia |
| Dehrin Solution | Latin | South Africa |
| Deselex Tablets | Latin | South Africa |
| Deslomed Syrup | Latin | South Africa |
| DESLORATADIN +PHARMA | Latin | Czechia |
| HISTACARE | Latin | Bahrain |
| Neoclarityne Syrup | Latin | South Africa |
| ACUHIST | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.